학술논문

Correlative analyses of the SARC028 trial reveal an association between sarcoma-associated immune infiltrate and response to pembrolizumab
Document Type
Article
Source
In: Clinical Cancer Research. (Clinical Cancer Research, 15 March 2020, 26(6):1258-1266)
Subject
Language
English
ISSN
15573265
10780432